Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
26-08-24	US$0.000001	-.--%	20,000
26-08-19	US$0.000001	-.--%	100,004

Real-time OTC Markets

More quotes

Real-time OTC Markets 13:12:01 2023-12-08 EST			5-day change	1st Jan Change
0.000100 ^USD	-.--%		+9,900.00%	+9,900.00%

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Market Cap	1.07M 916K 859K 785K 1.48M 102M 1.49M 10.17M 3.94M 51.33M 4.01M 3.92M 170M	P/E 2016	-0.01x	P/E 2017	-0.03x
Enterprise Value	4.11M 3.53M 3.31M 3.03M 5.71M 392M 5.74M 39.22M 15.2M 198M 15.44M 15.11M 656M	EV / Sales 2016	127x	EV / Sales 2017	-
Free-Float	99.91%	Yield 2016 *	-	Yield 2017	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI
17-12-30	An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	CI
17-11-29	An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	CI
17-09-15	Pazoo, Inc. Announces Executive Changes	CI
17-04-03	Pazoo, Inc. cancelled the transaction announced on April 4, 2014	CI
16-07-14	Pazoo, Inc Implements New Validating of Testing	CI
16-06-18	Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	CI
16-04-26	Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	CI
16-03-30	Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	CI
16-03-15	Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	CI
15-11-09	Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	CI
15-07-09	Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	CI

22-10-28	PAZOO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
20-12-07	PAZOO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
18-11-14	Pazoo : Posts Conference Call Recording	PR
18-10-31	Pazoo, Inc. : Will Hold Conference Call Thursday November 8, 2018/Pazoo Website Back Up	PR
18-10-11	Pazoo : MA & Associates LLC Accepts First Samples and Begins Testing	PR

Pazoo, Inc. Stock

Stocks

PZOO

US70454Q3048

Healthcare Facilities & Services

Valuation: Pazoo, Inc.

Latest news : Pazoo, Inc.

Press Releases: Pazoo, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Pazoo, Inc.

Medical & Diagnostic Laboratories

Financials

Company Profile

Quotes

1 week	+9,900.00%
Current month	+9,900.00%
1 month	+9,900.00%
3 months	+9,900.00%
6 months	+9,900.00%
Current year	+9,900.00%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PAZOO, INC.	-.--%	+9,900.00%	+9,900.00%	-.--%	2.69K
NATERA, INC.	+0.15%	+3.33%	+102.70%	+505.12%	48.53B
LABCORP HOLDINGS INC.	-0.36%	+1.48%	+20.42%	+57.99%	27.39B
SONIC HEALTHCARE LIMITED	-1.86%	-14.86%	-15.86%	-37.72%	7.23B
RADNET, INC.	+0.07%	+1.61%	+8.76%	+141.75%	6.05B
DR. LAL PATHLABS LIMITED	+1.23%	+2.65%	+17.11%	+77.19%	3.35B
GENEDX HOLDINGS CORP.	+3.14%	+12.98%	-28.72%	+2,007.49%	2.61B
NEOGENOMICS, INC.	+3.78%	+3.69%	+157.76%	+25.05%	2.16B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-1.45%	+1.24%	-7.80%	-51.91%	2.02B
FLEURY S.A.	-0.43%	+1.81%	+31.52%	+24.07%	1.97B
Average	+0.45%	+3.45%	+1,018.59%	+274.90%	10.13B
Weighted average by Cap.	+0.04%	+5.27%	+57.77%	+317.64%

	2016	2017
Net sales	30.52K 26.19K 24.58K 22.45K 42.37K 2.91M 42.58K 291K 113K 1.47M 115K 112K 4.86M	-
Net income	-8.8M -7.55M -7.09M -6.47M -12.21M -839M -12.27M -83.85M -32.5M -423M -33.02M -32.31M -1.4B	-3.54M -3.04M -2.86M -2.61M -4.92M -338M -4.95M -33.79M -13.1M -171M -13.31M -13.02M -565M
Net Debt	3.44M 2.96M 2.77M 2.53M 4.78M 328M 4.81M 32.83M 12.72M 166M 12.93M 12.65M 549M	3.05M 2.61M 2.45M 2.24M 4.23M 291M 4.25M 29.04M 11.26M 147M 11.44M 11.19M 486M